Company Profile
Fonar Stock Price, News & Analysis
- Ticker:
- FONR
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
19.09 USD (-0.10%)
Close
Last updated: June 2, 2026
120M USD
Market cap
Why the stock is moving
Current closing-price context is not available for FONR.
Company overview
Business overview
FONAR is a medical imaging company focused on MRI systems and related diagnostic equipment. Its business centers on imaging technology rather than biotech or therapeutics.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, FONAR sits in medical imaging devices.
Business Model Characteristics
The company depends on equipment demand, imaging utilization, and the performance of its MRI platform.
Position Within the Biotechnology Landscape
FONAR is outside biotech and belongs to the imaging-device layer of healthcare.
Future catalysts
Fonar’s catalysts are MRI-system demand and recurring-service execution. This is a steady hardware / imaging business, so the market cares about utilization and service revenue.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026
CLPT · Source: ClearPoint Neuro
- 02
- 03
ClearPoint Neuro Reports First Quarter 2026 Results
CLPT · Source: ClearPoint Neuro
- 04
- 05
ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026
CLPT · Source: ClearPoint Neuro
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Fonar (FONR)?
Fonar (FONR) most recently closed at 19.09 USD, a -0.10% move versus the previous session.
What is the market cap of Fonar (FONR)?
Fonar currently has a market capitalization of 120M USD on BioPharmSignal.
What does Fonar do?
FONAR is a medical imaging company focused on MRI systems and related diagnostic equipment. Its business centers on imaging technology rather than biotech or therapeutics.
On which exchange is FONR stock listed?
Fonar (FONR) is associated with NASDAQ, United States, Biopharma.
What is Fonar?
Fonar’s catalysts are MRI-system demand and recurring-service execution.
Which conditions is Fonar targeting with Fonar?
Fonar’s catalysts are MRI-system demand and recurring-service execution.
How does Fonar describe recent progress with Fonar?
Fonar’s catalysts are MRI-system demand and recurring-service execution.
What is MRI-system?
Fonar’s catalysts are MRI-system demand and recurring-service execution.